title: HIV-1-suppressive factors are secreted by CD4+ T cells during primary immune responses.
abstract: CD4+ T cells are required for immunity against many viral infections, including HIV-1 where a positive correlation has been observed between strong recall responses and low HIV-1 viral loads. Some HIV-1-specific CD4+ T cells are preferentially infected with HIV-1, whereas others escape infection by unknown mechanisms. One possibility is that some CD4+ T cells are protected from infection by the secretion of soluble HIV-suppressive factors, although it is not known whether these factors are produced during primary antigen-specific responses. Here, we show that soluble suppressive factors are produced against CXCR4 and CCR5 isolates of HIV-1 during the primary immune response of human CD4+ T cells. This activity requires antigenic stimulation of naïve CD4+ T cells. One anti-CXCR4 factor is macrophage-derived chemokine (chemokine ligand 22, CCL22), and anti-CCR5 factors include macrophage inflammatory protein-1 alpha (CCL3), macrophage inflammatory protein-1 beta (CCL4), and RANTES (regulated upon activation of normal T cells expressed and secreted) (CCL5). Intracellular staining confirms that CD3+CD4+ T cells are the source of the prototype HIV-1-inhibiting chemokines CCL22 and CCL4. These results show that CD4+ T cells secrete an evolving HIV-1-suppressive activity during the primary immune response and that this activity is comprised primarily of CC chemokines. The data also suggest that production of such factors should be considered in the design of vaccines against HIV-1 and as a mechanism whereby the host can control infections with this virus.
authors.affiliation: Institute of Human Virology, Biotechnology Institute, and Department of Microbiology and Immunology, School of Medicine, University of Maryland, Baltimore, MD 21201, USA.
authors.forename: Sayed F
authors.initials: SF
authors.lastname: Abdelwahab
authors.forename: Fiorenza
authors.initials: F
authors.lastname: Cocchi
authors.forename: Kenneth C
authors.initials: KC
authors.lastname: Bagley
authors.forename: Roberta
authors.initials: R
authors.lastname: Kamin-Lewis
authors.forename: Robert C
authors.initials: RC
authors.lastname: Gallo
authors.forename: Anthony
authors.initials: A
authors.lastname: DeVico
authors.forename: George K
authors.initials: GK
authors.lastname: Lewis
mesh_terms: D000941:Antigens / Q000276:immunology; D017252:CD3 Complex / Q000096:biosynthesis; D015704:CD4 Antigens / Q000276:immunology; D015496:CD4-Positive T-Lymphocytes / Q000378:metabolism*; D054422:Chemokine CCL22; D018946:Chemokine CCL5 / Q000378:metabolism; D018925:Chemokines / Q000378:metabolism; D019742:Chemokines, CC / Q000378:metabolism; D004797:Enzyme-Linked Immunosorbent Assay; D005434:Flow Cytometry; D015658:HIV Infections; D015497:HIV-1 / Q000378:metabolism*; D006801:Humans; D019713:Receptors, CCR5 / Q000378:metabolism; D019718:Receptors, CXCR4 / Q000378:metabolism; D013997:Time Factors
chemical_list: D000941:Antigens; C515482:CCL22 protein, human; D017252:CD3 Complex; D015704:CD4 Antigens; D054422:Chemokine CCL22; D018946:Chemokine CCL5; D018925:Chemokines; D019742:Chemokines, CC; D019713:Receptors, CCR5; D019718:Receptors, CXCR4